Related Experiment Video

Updated: Jul 16, 2026

Visualization of Inflammatory Caspases Induced Proximity in Human Monocyte-Derived Macrophages
08:41

Visualization of Inflammatory Caspases Induced Proximity in Human Monocyte-Derived Macrophages

Published on: April 6, 2022

Inflammatory caspases: targets for novel therapies

Sigrid Cornelis1, Kristof Kersse, Nele Festjens

  • 1Department for Molecular Biomedical Research, VIB, B9052 Ghent, Belgium.

Current Pharmaceutical Design
|February 22, 2007
PubMed

Insights

Inflammatory caspases are key targets for treating inflammatory diseases like sepsis and ALS. Inhibitors show promise in preclinical models and early clinical trials for conditions such as rheumatoid arthritis.

Area of Science:

  • Biochemistry
  • Immunology
  • Pharmacology

Background:

  • Inflammatory caspases play crucial roles in immune responses and disease pathogenesis.
  • Dysregulation of inflammatory caspases is implicated in various chronic and acute inflammatory conditions.

Purpose of the Study:

  • To review the biochemistry and activation mechanisms of inflammatory caspases.
  • To explore the therapeutic potential of targeting inflammatory caspases in diseases including sepsis, Crohn's disease, rheumatoid arthritis, traumatic brain injury, and amyotrophic lateral sclerosis (ALS).

Main Methods:

  • Summarizing evidence from experimental disease models validating strategies targeting inflammatory caspases.
  • Discussing clinical studies of inflammatory caspase inhibitors (e.g., VX-740, VX-765) in rheumatoid arthritis and osteoarthritis.

Main Results:

  • Proof-of-principle evidence from disease models supports targeting inflammatory caspases.
  • Clinical studies are investigating the efficacy of specific caspase inhibitors for inflammatory conditions.

Conclusions:

  • Targeting inflammatory caspases represents a valid therapeutic strategy for multiple pathologies.
  • Novel peptidomimetic and non-peptide inhibitors are being developed for improved clinical profiles.

More Related Videos

Evaluation of Caspase Activation to Assess Innate Immune Cell Death10:23

Evaluation of Caspase Activation to Assess Innate Immune Cell Death

Published on: January 20, 2023

Identifying Caspases and their Motifs that Cleave Proteins During Influenza A Virus Infection08:16

Identifying Caspases and their Motifs that Cleave Proteins During Influenza A Virus Infection

Published on: July 21, 2022

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...